Accelerate Diagnostics, Inc. (AXDX): חובות להיוון בספרים

This chart of the debt-to-equity ratio demonstrates the dynamics of the credit load, where 0.00 represents the current level of the metric. Accelerate Diagnostics (AXDX) complies with chemical reagent utilization and energy saving standards. Stable revenue is ensured by tying clinics to proprietary consumables for Inertia systems. However, expansion is hindered by aggressive pressure from industry behemoths integrating similar functionality into their own platforms.

Accelerate Diagnostics (AXDX) develops its business through the sale of rapid diagnostic systems and consumables. This indicator compares total liabilities to the combined value of equity and debt capital. Analyzing the share of borrowed funds within the firm's book capitalization allows for an assessment of the degree of financial leverage. High values signal risks during fluctuations in revenue from hospitals. The trend of this metric determines the stability of the company's financing structure.